45 CFR § 180 compliance
F · 50
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
5,052
Insurances with rates
2
CPT / HCPCS codes
3,640
Source MRF
Most expensive procedures (gross)
S3399
$8,454,047
ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT
Gross
$11,272,063
C9399
$2,310,000
BETIBEGLOGENE AUTOTEMCEL 2 X 10EXP6 TO 20 X 10EXP6 CELL/ML IV SUSP
Gross
$3,080,000
Q2042
$1,834,688
TISAGENLECLEUCEL 0.2 X10EXP6 TO 2.5X10EXP8 CELL INTRAVENOUS SUSPENSION
Gross
$2,446,250
Q2055
$1,620,319
IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 460 X 10EXP6 CELL IV SUSPENSION
Gross
$2,160,425
Q2054
$1,584,784
LISOCABTAGENE MARALEUCEL(CD8) 1.5X TO 70X 10EXP6 CELL/ML IV SUSP(1OF2)
Gross
$2,113,045
Q2041
$1,541,138
AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION
Gross
$2,054,850
Q2053
$1,541,138
BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION
Gross
$2,054,850
J2326
$514,977
NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION
Gross
$686,637
J7330
$235,134
IMPLANT, MACI FINAL, PRODUCT ASSEMBLED, DOUBLE
Gross
$313,512
A9543
$230,954
KIT FOR YTTRIUM-90-IBRITUMOMAB 3.2 MG/2 ML INTRAVENOUS
Gross
$307,938
J9226
$187,438
HISTRELIN 50 MG (65 MCG/DAY) IMPLANT KIT
Gross
$249,917
J1823
$168,663
INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION
Gross
$224,883
J0223
$166,656
GIVOSIRAN 189 MG/ML SUBCUTANEOUS SOLUTION
Gross
$222,208
J9347
$161,802
TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION
Gross
$215,736
C9293
$152,044
GLUCARPIDASE 1,000 UNIT/1 ML IV INJECTION - RECONSTITUTED 1000 UNIT/ML
Gross
$202,725
J1305
$150,638
EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION
Gross
$200,850
J9228
$133,430
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$177,907
J9269
$128,250
TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION
Gross
$171,001
J0202
$117,036
ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION
Gross
$156,048
A9606
$111,047
RADIUM RA 223 DICHLOR 1,100 KBQ/ML (30 MICROCURIE/ML) INTRAVENOUS SOLN
Gross
$148,063
J3357
$102,608
USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE
Gross
$136,811
J9359
$100,096
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION
Gross
$133,462
Q2043
$100,023
SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION
Gross
$133,364
J1747
$98,751
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$131,667
J2507
$98,365
PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION
Gross
$131,154
J1303
$97,419
RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION
Gross
$129,891
J9118
$96,690
CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION
Gross
$128,921
38230
$91,568
HC BONE MARROW HARVEST TRANSPLANTATION ALLOGENEIC
Gross
$122,091
J9348
$87,460
NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION
Gross
$116,613
J9229
$87,357
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN
Gross
$116,476
J9266
$85,912
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION
Gross
$114,549
J9274
$84,054
TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION
Gross
$112,072
J7311
$78,930
FLUOCINOLONE 0.59 MG INTRAVITREAL IMPLANT
Gross
$105,240
J9600
$78,899
PORFIMER 2.5 MG/ML IV SYRINGE
Gross
$105,199
L8688
$77,067
GENERATOR, M1000-D, SENTIVA DUO
Gross
$102,756
J2350
$73,835
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION
Gross
$98,446
J9350
$73,780
MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION
Gross
$98,373
33240
$71,847
HC EP INSJ IMPLNTBL DEFIB PULSE GEN W/1 EXISTING LD
Gross
$95,796
J0638
$71,042
CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION
Gross
$94,723
A9604
$66,666
SAMARIUM SM 153 LEXIDRONAM 5,550 MBQ/3 ML INTRAVENOUS SOLUTION
Gross
$88,888
J9309
$64,721
POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION
Gross
$86,294
33289
$63,224
HC TCAT IMPL WRLS P-ART PRS SNR L-T HEMODYN MNTR
Gross
$84,298
J3241
$62,991
TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION
Gross
$83,988
J2502
$61,591
PASIREOTIDE PAMOATE 20 MG IM SUSPENSION
Gross
$82,122
J7170
$58,958
EMICIZUMAB-KXWH 150 MG/ML SUBCUTANEOUS SOLUTION
Gross
$78,611
J9029
$57,938
NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION
Gross
$77,250
J9298
$56,814
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION
Gross
$75,752
C2624
$53,438
DELIVERY SYS, CORDELLA AND PULM ARTERY SENSOR (IDE G1900020)
Gross
$71,250
J1628
$53,170
GUSELKUMAB 100 MG/ML SUBCUTANEOUS SYRINGE
Gross
$70,893
J9316
$52,718
PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN
Gross
$70,291
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| S3399 | ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT | $11,272,063 | $8,454,047 | — | — | 0 |
| C9399 | BETIBEGLOGENE AUTOTEMCEL 2 X 10EXP6 TO 20 X 10EXP6 CELL/ML IV SUSP | $3,080,000 | $2,310,000 | — | — | 0 |
| Q2042 | TISAGENLECLEUCEL 0.2 X10EXP6 TO 2.5X10EXP8 CELL INTRAVENOUS SUSPENSION | $2,446,250 | $1,834,688 | — | — | 0 |
| Q2055 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 460 X 10EXP6 CELL IV SUSPENSION | $2,160,425 | $1,620,319 | — | — | 0 |
| Q2054 | LISOCABTAGENE MARALEUCEL(CD8) 1.5X TO 70X 10EXP6 CELL/ML IV SUSP(1OF2) | $2,113,045 | $1,584,784 | — | — | 0 |
| Q2041 | AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION | $2,054,850 | $1,541,138 | — | — | 0 |
| Q2053 | BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION | $2,054,850 | $1,541,138 | — | — | 0 |
| J2326 | NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $686,637 | $514,977 | — | — | 0 |
| J7330 | IMPLANT, MACI FINAL, PRODUCT ASSEMBLED, DOUBLE | $313,512 | $235,134 | — | — | 0 |
| A9543 | KIT FOR YTTRIUM-90-IBRITUMOMAB 3.2 MG/2 ML INTRAVENOUS | $307,938 | $230,954 | — | — | 0 |
| J9226 | HISTRELIN 50 MG (65 MCG/DAY) IMPLANT KIT | $249,917 | $187,438 | — | — | 0 |
| J1823 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $224,883 | $168,663 | — | — | 0 |
| J0223 | GIVOSIRAN 189 MG/ML SUBCUTANEOUS SOLUTION | $222,208 | $166,656 | — | — | 0 |
| J9347 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION | $215,736 | $161,802 | — | — | 0 |
| C9293 | GLUCARPIDASE 1,000 UNIT/1 ML IV INJECTION - RECONSTITUTED 1000 UNIT/ML | $202,725 | $152,044 | — | — | 0 |
| J1305 | EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION | $200,850 | $150,638 | — | — | 0 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $177,907 | $133,430 | — | — | 0 |
| J9269 | TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION | $171,001 | $128,250 | — | — | 0 |
| J0202 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION | $156,048 | $117,036 | — | — | 0 |
| A9606 | RADIUM RA 223 DICHLOR 1,100 KBQ/ML (30 MICROCURIE/ML) INTRAVENOUS SOLN | $148,063 | $111,047 | — | — | 0 |
| J3357 | USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE | $136,811 | $102,608 | — | — | 0 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $133,462 | $100,096 | — | — | 0 |
| Q2043 | SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION | $133,364 | $100,023 | — | — | 0 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $131,667 | $98,751 | — | — | 0 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $131,154 | $98,365 | — | — | 0 |
| J1303 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $129,891 | $97,419 | — | — | 0 |
| J9118 | CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION | $128,921 | $96,690 | — | — | 0 |
| 38230 | HC BONE MARROW HARVEST TRANSPLANTATION ALLOGENEIC | $122,091 | $91,568 | — | — | 0 |
| J9348 | NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION | $116,613 | $87,460 | — | — | 0 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $116,476 | $87,357 | — | — | 0 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $114,549 | $85,912 | — | — | 0 |
| J9274 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION | $112,072 | $84,054 | — | — | 0 |
| J7311 | FLUOCINOLONE 0.59 MG INTRAVITREAL IMPLANT | $105,240 | $78,930 | — | — | 0 |
| J9600 | PORFIMER 2.5 MG/ML IV SYRINGE | $105,199 | $78,899 | — | — | 0 |
| L8688 | GENERATOR, M1000-D, SENTIVA DUO | $102,756 | $77,067 | — | — | 0 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $98,446 | $73,835 | — | — | 0 |
| J9350 | MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION | $98,373 | $73,780 | — | — | 0 |
| 33240 | HC EP INSJ IMPLNTBL DEFIB PULSE GEN W/1 EXISTING LD | $95,796 | $71,847 | — | — | 0 |
| J0638 | CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $94,723 | $71,042 | — | — | 0 |
| A9604 | SAMARIUM SM 153 LEXIDRONAM 5,550 MBQ/3 ML INTRAVENOUS SOLUTION | $88,888 | $66,666 | — | — | 0 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $86,294 | $64,721 | — | — | 0 |
| 33289 | HC TCAT IMPL WRLS P-ART PRS SNR L-T HEMODYN MNTR | $84,298 | $63,224 | — | — | 0 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $83,988 | $62,991 | — | — | 0 |
| J2502 | PASIREOTIDE PAMOATE 20 MG IM SUSPENSION | $82,122 | $61,591 | — | — | 0 |
| J7170 | EMICIZUMAB-KXWH 150 MG/ML SUBCUTANEOUS SOLUTION | $78,611 | $58,958 | — | — | 0 |
| J9029 | NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION | $77,250 | $57,938 | — | — | 0 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $75,752 | $56,814 | — | — | 0 |
| C2624 | DELIVERY SYS, CORDELLA AND PULM ARTERY SENSOR (IDE G1900020) | $71,250 | $53,438 | — | — | 0 |
| J1628 | GUSELKUMAB 100 MG/ML SUBCUTANEOUS SYRINGE | $70,893 | $53,170 | — | — | 0 |
| J9316 | PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN | $70,291 | $52,718 | — | — | 0 |
Showing top 50 of 5,052 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.